The UK market for private GP electronic health records (EHRs) will likely grow due to increased demand for private healthcare, regulatory standards, and technological advancements. A rise in private sector preference and scarcity of primary physicians is driving the need for EHRs. Advances in AI and wearables integrated with EHRs also stimulate demand. However, cyber-security concerns and technical issues may limit EHR adoption among some providers.
Wall Street’s Leaders and Laggards of 2024
2024 was a mixed year for biopharma stocks, with the iShares Biotechnology ETF and SPDR S&P Biotech ETF experiencing small decreases. Federal Reserve decisions caused
